Q3 2025 · 13F-HR
22NW, LPholdings as filed
Filed 2025-11-14 · accession 0001214659-25-016649
$212.3M
Reported value
21
Positions
2025-09-30
Period end
The Brief · 22NW, LP · Q3 2025
AI · grounded in 13F
22NW, LP established a new position in ANEB valued at $38.7M. The fund also initiated new stakes in FSTR for $35.4M and LFCR for $20.1M. Additional new positions include NKTR at $18.8M and SRI at $16.0M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $38.7M | 18.2% | 15,467,300 | Common | SOLE |
| 350060109 | FSTR | FOSTER L B CO | $35.4M | 16.7% | 1,313,121 | Common | SOLE |
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $20.1M | 9.49% | 1,254 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $18.8M | 8.88% | 331,115 | Common | SOLE |
| 86183P102 | SRI | STONERIDGE INC | $16.0M | 7.56% | 2,105,600 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $13.6M | 6.40% | 358,325 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $8.9M | 4.20% | 923,679 | Common | SOLE |
| 230215105 | CULP | CULP INC | $8.3M | 3.91% | 1,859,061 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $7.7M | 3.63% | 820,653 | Common | SOLE |
| 23331S100 | DHX | DHI GROUP INC | $5.7M | 2.67% | 2,036,988 | Common | SOLE |
| 71742W103 | PFX | PHENIXFIN CORP | $5.6M | 2.64% | 117,885 | Common | SOLE |
| 578605107 | MEC | MAYVILLE ENGR CO INC | $5.5M | 2.59% | 399,890 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $4.8M | 2.27% | 586,519 | Common | SOLE |
| 904677200 | UFI | UNIFI INC | $4.7M | 2.19% | 977,639 | Common | SOLE |
| 218683100 | CMT | CORE MOLDING TECHNOLOGIES IN | $4.6M | 2.16% | 222,738 | Common | SOLE |
| H00501108 | AEBI | AEBI SCHMIDT HLDG AG | $4.3M | 2.04% | 347,840 | Common | SOLE |
| 307675108 | FB1 | FARMER BROS CO | $3.3M | 1.58% | 1,955,526 | Common | SOLE |
| 878155308 | TISI | TEAM INC | $2.8M | 1.33% | 170,187 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $1.6M | 0.78% | 636,364 | Common | SOLE |
| 86272A305 | SSKN | STRATA SKIN SCIENCES INC | $1.1M | 0.52% | 536,995 | Common | SOLE |
| 744375304 | — | PSYCHEMEDICS CORPORATION CMN | $582,432 | 0.27% | 276,034 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.